Alibaba Group said it has agreed to sell medical device and healthcare product categories from Tmall Pharmacy to its Hong Kong-listed healthcare affiliate in return for HK$10.6bn ($1.4bn) in newly issued shares in the latter company.
阿里巴巴集團(Alibaba Group)宣布，已同意將天貓醫藥館(Tmall Pharmacy)的醫療器械及保健用品等產品及服務出售給在香港上市的關聯企業阿里健康信息技術(Alibaba Health Information Technology)，換取價值106億港元（合14億美元）的阿里健康新股。
您已閱讀22%（387字），剩余78%（1365字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。